![]() ![]() It receives SMS messages and displays them on a dot matrix screen. The project I ended up putting together at the ThingMonk hack day was a pager. There’s little risk of running out of memory – my simple projects never reported more that 0% usage! I build a pager One thing that stands out straight away is that the capacity of the LinkIt ONE is huge compared to a more typical ATmega328 based Arduino like the Uno. With a fresh install of the IDE in place it was easy to get the blinking LED ‘hello world’ demo going. I then moved on to a fight with Windows 8 to install the drivers. InstallationĪfter a brief fight with the Mediatek registration wall I found the SDK on github. It isn’t actually a cellphone SoC, and (according to the pdf documentation) is intended for wearables. The system on chip ( SoC) used by the LinkIt ONE is Mediatek’s MT2502A. There’s also a LiPoly battery in the box meaning that you can straight away make projects that could be put in a tupperware box, left in a field and send data back to base – all for $79 from Seeed Studios (who Mediatek partnered with for distribution). It comes with antennae for cellular (SMS/GPRS), bluetooth/wifi and GPS. The board has the familiar Arduino form factor, and can be programmed from the Arduino IDE, so it ends up feeling like an Arduino bolted on to a mobile phone. The LinkIt ONE development board is an open source, high performance board for prototyping Wearables and IoT devices I saw a ton of things that were taking advantage of low end, low cost and low power data services – mainly 1G/2G stuff like SMS and GPRS (not power hungry high bandwidth 3G). The coolest thing I saw at the event was the Brewbot (which doesn’t have any cellular), but not far away was a stand showing off Mediatek’s LinkIt ONE. I was at the Web Summit in Dublin a month ago, and one of the key themes that stood out for me was cellular connectivity for devices. Percent changes in lipid index and macrophage grade were positively correlated with the changes in serum LDL-C and C-reactive protein levels, and negatively correlated with the change in serum EPA/arachidonic acid and 18-hydroxyeicosapentaenoic acid (EPA bioactive metabolite) level.Ĭompared with rosuvastatin 2.5 mg/day, rosuvastatin 10 mg/day and EPA 1,800 mg/day significantly stabilised non-obstructive neoatherosclerotic plaques.TL DR – The LinkIt ONE is an awesome Arduino, with a ton of great integrated peripherals, but I fear there’s too much of a gap between Arduino style development and building the next generation of connected things – though hopefully that gets covered by the forthcoming Eclipse based SDK. Lipid index change and percent changes in macrophage grade were significantly lower in the intensive therapy group than in the standard therapy group (-53.6 vs 310.1, p=0.001 -37.0% vs 35.3%, p<0.001 respectively). The serum low-density lipoprotein cholesterol (LDL-C) level decreased significantly from baseline to 12-month follow-up in the intensive therapy group (89 mg/dL to 70 mg/dL p<0.001), while no change occurred in the standard therapy group. Follow-up OCT was performed one year later to evaluate serial changes in neoatherosclerosis. ![]() We randomly assigned 50 patients with non-obstructive neoatherosclerotic plaques detected on OCT to receive either rosuvastatin 10 mg/day and EPA 1,800 mg/day (intensive therapy group) or rosuvastatin 2.5 mg (standard therapy group). We aimed to assess the effect of 10 mg/day of rosuvastatin plus eicosapentaenoic acid (EPA) versus 2.5 mg/day of rosuvastatin on the extent of neoatherosclerosis using optical coherence tomography (OCT). ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |